Literature DB >> 19609644

Some patients with NHL possessed immunoreactivity to gliadin and to cow's milk proteins.

Zorica D Juranić1, Irina Besu2, Svetislav Jelić2, Aleksandra Konić-Ristić3, Suzana Matković2, Ljiljana Janković4, Dušica Gavrilović2, Branka Radojčić5, Ivana Minić2.   

Abstract

Non-Hodgkin lymphoma (NHL) represents heterogeneous group of diseases either B, or T cell origin. In order to assess whether food antigens contribute to the imbalance of immune response, the aim of this work was screening the sera of patients with (mostly) B cell NHL, and of people with non-malignant health disorders (NMD), as well as of healthy people for their immunoreactivity to food constituent gliadin, and to cow's milk proteins. Data obtained by ELISA tests show the existence of the enhanced immunoreactivity to food antigens in some NHL patients, as well as in some people with NMD. The high degree of coincidence in the presence of enhanced levels of immune complexes in circulation (CIC) and of immunoreactivity with gliadin in immunofixation (after the serum protein electrophoresis in agarose gel in veronal buffer, at pH 8.6) especially in NHL patients points that some antigliadin immunoreactivity unrevealed in ELISA tests could be hidden in CIC. This, only in the presence of malignant genotype, as well as the enhanced levels of CIC in some of NHL patients could both, at least partially contribute to the persistent non-specific support of disease. They call for the new research of the clinical importance of both, the elevated humoral immunity to food antigens (gluten, cow's milk proteins) for the course of this very severe hematological disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609644     DOI: 10.1007/s12185-009-0383-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

1.  Hepatitis C virus association with non-Hodgkin's lymphoma.

Authors:  A Timurağlu; D Colak; D Oğünç; I Karadoğan; L Undar
Journal:  Haematologia (Budap)       Date:  1999

2.  Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas.

Authors:  A Tavani; C La Vecchia; S Franceschi; D Serraino; A Carbone
Journal:  Eur J Cancer Prev       Date:  2000-02       Impact factor: 2.497

Review 3.  Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias.

Authors:  G Merlini; M Farhangi; E F Osserman
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

Review 4.  Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.

Authors:  A P Andonopoulos; M Tiniakou; M Melachrinou; H Sfountouris; A Bounas; C Zervas; N C Zoumbos
Journal:  Rev Rhum Engl Ed       Date:  1997-05

5.  The use of polyethyleneglycol for immune complex detection in human sera.

Authors:  I Ríha; V Hasková; J Kaslík; M Maierová; J Stránský
Journal:  Mol Immunol       Date:  1979-07       Impact factor: 4.407

6.  Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.

Authors:  A Chloraki-Bobota; C Megalakaki; P Repousis; Ir Chalkiopoulou; I Lalaki; D T Trafalis; A E Athanassiou; Chr Mitsouli-Mentzikof
Journal:  J BUON       Date:  2006 Oct-Dec       Impact factor: 2.533

7.  Partial remission of psoriasis following rituximab therapy for non-Hodgkin lymphoma.

Authors:  Fiza Singh; Jeffrey M Weinberg
Journal:  Cutis       Date:  2005-09

8.  Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy.

Authors:  Antonio Tursi; Giovanni Brandimarte; Monica Torello
Journal:  J Clin Gastroenterol       Date:  2004-04       Impact factor: 3.062

Review 9.  The epidemiology of non-Hodgkin's lymphoma.

Authors:  Susan G Fisher; Richard I Fisher
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

10.  Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.

Authors:  J S Kim; S J Chung; Y S Choi; J H Cheon; C W Kim; S G Kim; H C Jung; I S Song
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

View more
  1 in total

1.  Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo.

Authors:  Marija Dorđić; Ivana Z Matić; Ivana Filipović-Lješković; Radan Džodić; Miomir Sašić; Aleksandra Erić-Nikolić; Ana Vuletić; Branka Kolundžija; Ana Damjanović; Nađa Grozdanić; Srđan Nikolić; Janko Pralica; Danijela Dobrosavljević; Sanvila Rašković; Slađana Andrejević; Zorica Juranić
Journal:  BMC Complement Altern Med       Date:  2012-07-26       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.